---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-23-010092"
form_type: "8-K"
ticker: "DRMA"
cik: "0001853816"
company_name: "Dermata Therapeutics, Inc."
filed_at: "2023-08-03T23:59:59+00:00"
generated_at: "2026-06-12T09:29:34.001991+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Dermata auditor MHM resigns; prior audits flagged going concern; equity plan expanded

## Summary
- MHM will not stand for reappointment as auditor for FY2024; will serve until FY2023 audit or new auditor appointed.
- MHM's prior audit reports for FY2021 and FY2022 contained a going-concern explanatory paragraph.
- Audit committee has initiated process to select a new independent registered public accounting firm.
- Shareholders approved amendment to increase shares under 2021 Omnibus Equity Incentive Plan by 513,150 to 629,069.
- David Hale, Steven Mento, and Brittany Bradrick elected as Class II directors for three-year terms.

## SEC filing metadata
- accession: 0001654954-23-010092
- form_type: 8-K
- ticker: DRMA
- cik: 0001853816
- company_name: Dermata Therapeutics, Inc.
- filed_at: 2023-08-03T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1853816/000165495423010092/0001654954-23-010092-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1853816/000165495423010092/drma_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-23-010092
- JSON: https://secwatch.observer/filing/0001654954-23-010092.json
- Plain text: https://secwatch.observer/filing/0001654954-23-010092.txt

## Key facts
- Shareholder Votes
  Dermata Therapeutics, Inc. shareholders approved Election of three Class II directors.
  - Proposal: director election
  - Outcome: passed
  source text: The votes were cast for this matter as follows: Nominee For Against Broker Non-Votes David Hale 463,516.75 255,950 750,505 Steven J. Mento, Ph.D. 463,698.75 255,768 750,505 Brittany Bradrick 687,187.75 32,279 750,505
  evidence_url: https://www.sec.gov/Archives/edgar/data/1853816/000165495423010092/0001654954-23-010092-index.htm
- Shareholder Votes
  Dermata Therapeutics, Inc. shareholders approved Ratification of appointment of Mayer Hoffman McCann P.C. as independent registered public accounting firm at the 2023-12-31 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-12-31
  source text: The proposal to ratify the appointment of Mayer Hoffman McCann P.C. as the Company’s independent registered public accounting firm for the Company’s fiscal year ending December 31, 2023, was approved based upon the following votes: For Against Abstain 1,432,787.75 36,347 837
  evidence_url: https://www.sec.gov/Archives/edgar/data/1853816/000165495423010092/0001654954-23-010092-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.